MedTrace Logo

Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」

NCT02211638 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18113

Last updated 2018-11-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to gain an understanding of the actual use of candesartan cilexetil (Blopress) in patients with hypertension, and to examine the changes in parameters such as blood pressure.

Conditions

Interventions

DRUG

Candesartan Cilexetil

Candesartan Cilexetil tablet

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-13
Primary Completion
2013-04-25
Completion
2013-04-25

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02211638 on ClinicalTrials.gov